{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidubgr42w7vx7zyfb7v55jkkmwk3f4yzt6hgawzrk5gxe7lymg3d4",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mj3o3z45lxc2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreia7iz6aiv5krtoebffcwqx7beuqmtb6yote6dfdvdekcrqnagfo5a"
    },
    "mimeType": "image/jpeg",
    "size": 78541
  },
  "path": "/news/2026-04-coding-rna-therapeutic-cancer.html",
  "publishedAt": "2026-04-09T16:00:04.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Northwestern Medicine scientists have discovered that a specific long non-coding RNA activates oncogenic signaling pathways in prostate cancer cells and drives tumor progression, underscoring its potential as a therapeutic target, according to a recent study published in Nature Communications. Rendong Yang, Ph.D., associate professor of Urology and a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, was co-corresponding author of the study.",
  "title": "Long non-coding RNA may be a promising therapeutic target for cancer"
}